Researchers Identify Molecular 'Switch' Driving Alzheimer's Brain Inflammation

Researchers at Scripps Research have identified a critical molecular mechanism that appears to trigger the chronic brain inflammation characteristic of Alzheimer’s disease. The study, published in Cell Chemical Biology, highlights how a protein known as STING becomes chemically altered, causing the brain's immune system to remain in a state of constant, harmful activation. This persistent immune response damages the vital connections between nerve cells, contributing to the cognitive decline associated with the disease.

The core of this discovery lies in a process called S-nitrosylation (SNO), where a chemical modification forces the STING protein into an overactive state. By analyzing human brain samples and stem cell-derived models, the team confirmed that this specific modification is a key driver of neuroinflammation. When researchers blocked this chemical switch in mouse models, they observed a significant reduction in inflammation and successfully preserved the integrity of brain cell connections.

This finding is particularly significant because it provides a precise, druggable target for future therapeutic interventions. By understanding how environmental factors and aging can trigger this 'SNO-STORM' effect—a phenomenon where multiple proteins are disrupted simultaneously—scientists are closer to developing treatments that could halt or slow the progression of neurodegenerative conditions. The ability to 'turn off' this inflammatory switch offers a promising new strategy for protecting brain health in patients suffering from Alzheimer's and potentially other related disorders.